Lung-Sheng Lu
Overview
Explore the profile of Lung-Sheng Lu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
188
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sou F, Hsu C, Chiu Y, Wu C, Lu L, Kuo C, et al.
J Formos Med Assoc
. 2024 Apr;
124(3):246-252.
PMID: 38589275
Background: Statins may reduce the risk of recurrent gallstone disease by decreasing bile cholesterol saturation and pathogenicity. However, limited studies have investigated this issue. This study aimed to assess whether...
2.
Wang H, Huang P, Yang S, Wu M, Tai W, Chen C, et al.
Life (Basel)
. 2023 Sep;
13(9).
PMID: 37763266
Background: Gastroesophageal reflux disease (GERD) affects a significant proportion of individuals, with life stress being a contributing factor. This study aimed to investigate the correlation between psychosomatic evaluations, heart rate...
3.
Liu A, Tai W, Chiu S, Sou F, Yang S, Lu L, et al.
Infect Drug Resist
. 2023 Sep;
16:6167-6174.
PMID: 37724089
Background: Endoscopic Retrograde Cholangiopancreatography (ERCP), used for choledocholithiasis treatment, carries a risk of pyogenic liver abscess (PLA) due to communication between the biliary system and bowel contents. However, limited data...
4.
Lin W, Tai W, Chang C, Tu C, Feng I, Shieh M, et al.
Inflamm Bowel Dis
. 2023 Jan;
29(11):1730-1740.
PMID: 36626567
Background: This nationwide prospective registry study investigated the real-world effectiveness, safety, and persistence of vedolizumab (VDZ) in inflammatory bowel disease (IBD) patients in Taiwan. Disease relapse rates after VDZ discontinuation...
5.
Liang C, Chiu Y, Lu L, Wu C, Sou F, Chiu S, et al.
Life (Basel)
. 2022 Dec;
12(12).
PMID: 36556365
Background: Evidence supporting the feasibility of single-stage stone removal in patients with a moderate grade of acute cholangitis remains insufficient. The maximal size of a common bile-duct stone suitable for...
6.
Ko C, Yao C, Li Y, Lu L, Chou Y, Hu M, et al.
PLoS One
. 2022 Oct;
17(10):e0275723.
PMID: 36206286
Background And Aims: Endoscopic submucosal dissection (ESD) as an advanced endoscopic procedure can be considered for the removal of colorectal lesions with high suspicion of limited submucosal invasion or cannot...
7.
Tai W, Liang C, Bi K, Kuo C, Lu L, Wu C, et al.
Infect Drug Resist
. 2019 Oct;
12:2923-2931.
PMID: 31571945
Purpose: Steadily maintaining high intra-gastric PH is the major factor for successful eradication. It is important to search for a stronger PPI. Dexlansoprazole MR is a dual delayed release formulation...
8.
Kuo C, Chiu Y, Liang C, Wu C, Lu L, Tai W, et al.
BMC Gastroenterol
. 2019 Jun;
19(1):93.
PMID: 31215401
Background: The removal of large bile duct stones (> 15 mm) by conventional endoscopic sphincterotomy (EST) and endoscopic papillary balloon dilation (EPBD) can be challenging, requiring mechanical lithotripsy (ML) in...
9.
Liang C, Kuo C, Lu L, Wu C, Tsai C, Kuo M, et al.
Biomed J
. 2019 May;
42(2):131-136.
PMID: 31130249
Background: Conscious sedation is not routinely administered for therapeutic endoscopic retrograde cholangiopancreatography (ERCP) in many countries. The aim of our retrospective study was to compare the safety and rate of...
10.
Kuo C, Chiu Y, Liang C, Lu L, Tai W, Kuo Y, et al.
BMC Gastroenterol
. 2016 Jul;
16(1):70.
PMID: 27406119
Background: Difficult biliary cannulation in endoscopic retrograde cholangiopancreatography (ERCP) can result in failure of common bile duct (CBD) stone removal and pancreatitis. The present study aimed to report the efficacy...